NCT03381209View on ClinicalTrials.gov

The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 10, 2017

Primary Completion Date

November 10, 2017

Study Completion Date

November 10, 2017

Conditions

Muscle Relaxation

Interventions

DRUG

Sugammadex

sugammadex given based on 3 measurements of body weights

Trial Locations (1)

Unknown

Faculty of Medicine, Ain Shams University, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT03381209 - The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium. | Biotech Hunter | Biotech Hunter